Bli medlem
Bli medlem

Du är här

2014-04-10

Probi: Travel-friendly Probi Digestis® (Probi Mage®) launched in Sweden

A healthy digestive system is extra important when travelling
overseas. Travel Pack makes it easier than ever to bring Probi
Digestis® on your trip.

Travel Pack extends the Probi Digestis® consumer offering into a new
occasion and targets a group that consumes supplements containing
lactic acid bacteria mainly during travelling and holidays.

"Probi Digestis® makes an ideal travel companion. The new Travel Pack
will make it easier for consumers to bring Probi Digestis® when they
travel. The smaller pack size is also convenient for consumers who
want to try Probi Digestis®, but don't want to initially purchase the
larger standard packs," says Peter Nählstedt, CEO of Probi.

Sweden's most popular probiotic dietary supplement
Probi® is the leading brand in probiotic dietary supplements,
accounting for 50.5% of the Swedish market.* Probi's product
platform, Probi Digestis®, is based on the unique bacterium strain
Lactobacillus plantarum 299v (DSM 9843), also known as LP299V®, and
the efficacy of this product in gastrointestinal disorders is
well-documented, particularly in relation to Irritable Bowel Syndrome
(IBS).

Probi partners with leading companies, currently marketing Probi®
products in some 35 countries.

*GfK Medic Scope, 12 months, Dec 2013

FOR MORE INFORMATION, PLEASE CONTACT:
Peter Nählstedt, CEO, Probi, tel: +46 (0)46 286 89 23 or mob: +46
(0)723 86 99 83, e-mail: peter.nahlstedt@probi.se

Niklas Bjärum, VP Marketing & Sales, Probi, tel +46 46 286 89 67 or
mobile +46 705 38 88 64, e-mail: niklas.bjarum@probi.se

ABOUT PROBI
Probi AB is a Swedish publicly traded biotechnology company that
develops effective and well-documented probiotics. Through its
research, Probi has created a strong product portfolio in the
gastrointestinal health and immune system areas. The products are
available to consumers in more than 30 countries worldwide. The
customers are leading food, health-product and pharmaceutical
companies in the Functional Food and Consumer Healthcare segments.
Probi had sales of MSEK 102 in 2013. The Probi share is listed on
NASDAQ OMX Stockholm, Small-cap. Probi has approximately 4,000
shareholders. Read more on www.probi.se.

-----------------------------------------------------------
http://news.cision.com/probi/r/travel-friendly-probi-digestis---probi-ma...
http://mb.cision.com/Main/1556/9567118/231771.pdf

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.